Three proteins (TNFAIP2, SAMSN1, CD163) for the third Cox survival analysis model represented significant independence from the clinical parameters, meaning that these proteins may be survival predictors regardless of clinical parameters such as gender, age at diagnosis, tumor content (%) or disease stage. The gene discussed is CD163; the disease is neoplasm.